Work

Dengue vaccine clinical trials in India — An opportunity to inform the global response to a re-emerging disease challenge

Year: 2019

Type: article

Abstract: Dengue viral disease or dengue fever (DF) is among the most important globally re-emerging infectious diseases of the 21st century. The World Health Organization (WHO) estimates that every year 50–100 million symptomatic dengue virus (DENV) infections occur worldwide, resulting in approximately 500,000 hospitalizations, and 22,000 deaths, with most cases occurring in children (Bhatt et al., 2013; Gubler, 2002; Stanaway et al., 2016; World Health Organization, 2018; World Health Organization, 2019; World Health Organization South East Asia Regional Office, 2019).

Source: International Journal of Infectious Diseases

DOI: 10.1016/j.ijid.2019.03.016

Authors: Anthony Fauci, Emily Erbelding, Stephen Whitehead, M. Cristina Cassetti, F. Gray Handley, Ranjan Gupta

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Language: English

Topic: Mosquito-borne diseases and control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,750